Literature DB >> 21921051

A third-generation IMiD for MM.

Michele Cavo1.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21921051     DOI: 10.1182/blood-2011-07-364315

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Cereblon: promise and challenges for combating human diseases.

Authors:  Hyoung Kyu Kim; Jung Eun Seol; Sang Woo Ahn; Seungje Jeon; Chul-Seung Park; Jin Han
Journal:  Pflugers Arch       Date:  2021-09-22       Impact factor: 3.657

Review 2.  Cereblon in health and disease.

Authors:  Hyoung Kyu Kim; Tae Hee Ko; Bayalagmaa Nyamaa; Sung Ryul Lee; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Chul-Seung Park; Bernd Nilius; Jin Han
Journal:  Pflugers Arch       Date:  2016-06-24       Impact factor: 3.657

3.  Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis.

Authors:  Seung-Joo Yang; Seungje Jeon; Jeong Won Baek; Kwang Min Lee; Chul-Seung Park
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-26

Review 4.  New drugs in multiple myeloma - role of carfilzomib and pomalidomide.

Authors:  Artur Jurczyszyn; Wojciech Legieć; Grzegorz Helbig; Marek Hus; Sławomira Kyrcz-Krzemień; Aleksander B Skotnicki
Journal:  Contemp Oncol (Pozn)       Date:  2014-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.